Bayer Aktiengesellschaft 0P6S.IL Stock
Bayer Aktiengesellschaft Price Chart
Bayer Aktiengesellschaft 0P6S.IL Financial and Trading Overview
Bayer Aktiengesellschaft stock price | 0.0000 EUR |
Previous Close | 51.8 EUR |
Open | 51.99 EUR |
Bid | 51.86 EUR x 0 |
Ask | 52.92 EUR x 0 |
Day's Range | 51.79 - 52.4 EUR |
52 Week Range | 43.9 - 65.65 EUR |
Volume | 33.01K EUR |
Avg. Volume | 1.12M EUR |
Market Cap | 52.27B EUR |
Beta (5Y Monthly) | 1.184291 |
PE Ratio (TTM) | 17.11111 |
EPS (TTM) | -2.94 EUR |
Forward Dividend & Yield | 2.4 (4.63%) |
Ex-Dividend Date | May 2, 2023 |
1y Target Est | N/A |
0P6S.IL Valuation Measures
Enterprise Value | 86.27B EUR |
Trailing P/E | 17.11111 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.0353724 |
Price/Book (mrq) | 1.2588052 |
Enterprise Value/Revenue | 1.709 |
Enterprise Value/EBITDA | 7.559 |
Trading Information
Bayer Aktiengesellschaft Stock Price History
Beta (5Y Monthly) | 1.184291 |
52-Week Change | -17.32% |
S&P500 52-Week Change | 20.43% |
52 Week High | 65.65 EUR |
52 Week Low | 43.9 EUR |
50-Day Moving Average | 56.54 EUR |
200-Day Moving Average | 54.41 EUR |
0P6S.IL Share Statistics
Avg. Volume (3 month) | 1.12M EUR |
Avg. Daily Volume (10-Days) | 595.91K EUR |
Shares Outstanding | 982.42M |
Float | 982.39M |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 42.65% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 2.4 |
Trailing Annual Dividend Yield | 4.63% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.6472 |
Last Split Factor | 10:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 6.01% |
Operating Margin (ttm) | 15.53% |
Gross Margin | 61.49% |
EBITDA Margin | 22.60% |
Management Effectiveness
Return on Assets (ttm) | 3.90% |
Return on Equity (ttm) | 7.76% |
Income Statement
Revenue (ttm) | 50.49B EUR |
Revenue Per Share (ttm) | 51.39 EUR |
Quarterly Revenue Growth (yoy) | -1.70% |
Gross Profit (ttm) | 31.85B EUR |
EBITDA | 11.41B EUR |
Net Income Avi to Common (ttm) | 3.04B EUR |
Diluted EPS (ttm) | 3.06 |
Quarterly Earnings Growth (yoy) | -33.80% |
Balance Sheet
Total Cash (mrq) | 7.98B EUR |
Total Cash Per Share (mrq) | 8.12 EUR |
Total Debt (mrq) | 43.3B EUR |
Total Debt/Equity (mrq) | 105.56 EUR |
Current Ratio (mrq) | 1.152 |
Book Value Per Share (mrq) | 41.595 |
Cash Flow Statement
Operating Cash Flow (ttm) | 4.27B EUR |
Levered Free Cash Flow (ttm) | 3.46B EUR |
Profile of Bayer Aktiengesellschaft
Country | United Kingdom |
State | N/A |
City | Leverkusen |
Address | Kaiser-Wilhelm-Allee 1 |
ZIP | 51368 |
Phone | 49 214 30 1 |
Website | https://www.bayer.com |
Industry | Drug Manufacturers-General |
Sector(s) | Healthcare |
Full Time Employees | 101735 |
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases, as well as collaboration with Bicycle Therapeutics to develop bicyclic peptides. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
Q&A For Bayer Aktiengesellschaft Stock
What is a current 0P6S.IL stock price?
Bayer Aktiengesellschaft 0P6S.IL stock price today per share is 0.0000 EUR.
How to purchase Bayer Aktiengesellschaft stock?
You can buy 0P6S.IL shares on the IOB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bayer Aktiengesellschaft?
The stock symbol or ticker of Bayer Aktiengesellschaft is 0P6S.IL.
Which industry does the Bayer Aktiengesellschaft company belong to?
The Bayer Aktiengesellschaft industry is Drug Manufacturers-General.
How many shares does Bayer Aktiengesellschaft have in circulation?
The max supply of Bayer Aktiengesellschaft shares is 0.
What is Bayer Aktiengesellschaft Price to Earnings Ratio (PE Ratio)?
Bayer Aktiengesellschaft PE Ratio is now.
What was Bayer Aktiengesellschaft earnings per share over the trailing 12 months (TTM)?
Bayer Aktiengesellschaft EPS is -2.94 EUR over the trailing 12 months.
Which sector does the Bayer Aktiengesellschaft company belong to?
The Bayer Aktiengesellschaft sector is Healthcare.